These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1683799)

  • 1. Hematopoietic reconstitution and prevention of graft-versus-host disease with UVB-irradiated haploidentical murine spleen and marrow cells.
    Cohn ML; Cahill RA; Deeg HJ
    Blood; 1991 Dec; 78(12):3317-22. PubMed ID: 1683799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of allogeneic bone marrow and spleen cell transplantation in a murine model using ultraviolet-B light.
    Pamphilon DH; Alnaqdy AA; Godwin V; Preece AW; Wallington TB
    Blood; 1991 May; 77(9):2072-8. PubMed ID: 1826855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR; Majewski D
    Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of UVB prevention of graft versus host disease.
    Greenfeld JI; Chabot JA; Oluwole SF; Hardy MA
    J Surg Res; 1996 Jan; 60(1):137-41. PubMed ID: 8592404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cyclosporine-induced syngeneic graft-versus-host disease in bone marrow transplantation by UV-B irradiated bone marrow cells.
    Ohajekwe OA; James T; Hardy MA; Oluwole SF
    Bone Marrow Transplant; 1995 Apr; 15(4):627-32. PubMed ID: 7655391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term myeloid reconstitution following TBI is not adversely affected by doses of FK506 that abrogate lethal GVHD.
    Cooper MH; Patrene KD; Vecchini F; Austin CA; Markus PM; Boggs SS
    Bone Marrow Transplant; 1994 Sep; 14(3):355-62. PubMed ID: 7527689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
    Hess RA; Tschudy DP; Blaese RM
    J Immunol; 1987 Nov; 139(9):2845-9. PubMed ID: 2889780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor.
    del Rosario ML; Zucali JR; Kao KJ
    Blood; 1999 May; 93(10):3558-64. PubMed ID: 10233909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.
    Guo Y; Zhang L; Wan S; Sun X; Wu Y; Yu XZ; Xia CQ
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1035-41. PubMed ID: 24661874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice.
    Chen Y; Zeng D; Schlegel PG; Fidler J; Chao NJ
    Blood; 2000 Jan; 95(2):705-10. PubMed ID: 10627483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow Graft-Versus-Host Disease in Major Histocompatibility Complex-Matched Murine Reduced-Intensity Allogeneic Hemopoietic Cell Transplantation.
    Shahin K; Mattar Z; Silveira P; Hsu WH; Bendall L; Hart D; Bradstock KF
    Transplantation; 2017 Nov; 101(11):2695-2704. PubMed ID: 28319565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma-mediated prevention of graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice.
    Brok HP; Vossen JM; Heidt PJ
    Bone Marrow Transplant; 1997 Mar; 19(6):601-6. PubMed ID: 9085739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of graft-versus-host disease and bone marrow rejection: kinetics of induction of tolerance by UVB modulation of accessory cells and T cells in the bone marrow inoculum.
    Oluwole SF; Engelstad K; James T
    Blood; 1993 Mar; 81(6):1658-65. PubMed ID: 8453111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.